OncologyCE
LECTURECME

2019 Texas Oncology Clinical Educational Symposium

Author(s)/Faculty: David Andorsky, MD; Giada Bianchi, MD; Joyce O'Shaughnessy, MD; Alex Spira, MD, PhD
Release Date: 6/28/2019Expiration Date: 6/27/2020
Credit Type: CMENumber of Credits: 2.5
Content Type: LectureProvider:
Clinical outcomes for advanced cancers continue to improve through the identification as well as the development of novel diagnostic and therapeutic approaches that are tailored to individual patients. With continuing therapeutic advances, many tumor types now have several drug classes that, through tumor marker analysis, can be utilized for potential benefits in quality of life and survival. In this CME activity, experts in the field will address clinical advances in breast cancer, ALK+ NSCLC, chronic lymphocytic leukemia, and multiple myeloma as well as address the integration of therapeutic approaches into patient management algorithms.